Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-12-16

Clinical Trial Update: The TANTALUS® II System for the Treatment of Type 2 Diabetes: A Randomized Study [NA]

View source ↗

Summary

The randomized trial of the TANTALUS II System for treating type 2 diabetes was terminated. The update does not report trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TANTALUS II System

Snippet

Sponsor: MetaCure (USA), Inc. | Conditions: Type 2 Diabetes Mellitus, Overweight | NA | Status: TERMINATED